Abstract -Ethanol consumption is a high risk factor for oesophageal carcinoma and studies indicate that it acts as a promoter of A'-nitrosomethylbenzylamine (NMBzA)-induced oesophageal carcinogenesis. The studies described here indicate that ethanol-induced promotion was related with an increase in indices of lipid peroxidation in the target oesophageal tissue and that such an increase was associated with significant changes in the fatty acid profile of phospholipids. Young Sprague-Dawley rats were treated with NMBzA, 2.5 mg/kg body weight, three times a week for 3 weeks, and a week afterwards fed a 7% ethanolic diet that was continued until their death at 10 months. Cumulative ethane exhaled by rats was measured a week before their death and was found to increase significantly with NMBzA treatment but more so when followed by ethanol consumption. Cholesterol, phospholipids, and some indices of lipid peroxidation were measured in the oesophagus and liver. Whereas the levels of cholesterol and phospholipids were not affected in control-fed rats with or without the NMBzA treatment, ethanol consumption by either the untreated or NMBzA-treated rats caused a significant increase in the targeted oesophagus as well as the liver, the major site of ethanol and carcinogen metabolism. Ethanol consumption also increased all the indices of lipid peroxidation, i.e. malondialdehyde, lipid fluorescence, diene-and triene-conjugates; the largest increases were observed in rats that received both NMBzA and ethanol. A comparison of the fatty acid profile of phospholipids from the oesophagus and liver indicated significant alterations both with the NMBzA treatment and ethanol consumption. However, the fatty acid profile with regard to its peroxidability was significantly modified only with ethanol consumption and only in the oesophagus of the NMBzA-treated or untreated rats. Also, hepatic phospholipids showed a substantial increase in linolenate and no change in arachidonate, but the oesophageal phospholipids exhibited a pronounced increase in the levels of C18:3, C20:2, C20:3, C20:3' and C22:6 with a significant increase in arachidonate when use of ethanol followed the NMBzA treatment, suggesting a disorder in lipid and eicosanoid metabolism. We propose that ethanol may promote carcinogenesis through excessive cell proliferation induced by disordered lipid and eicosanoid metabolism that may cause a selective outgrowth of the initiated cells.
INTRODUCTION
carcinogens that induce tumours in the tissues that are at risk in alcoholics are often employed. Frequent alcohol use is associated with an jV-Nitrosomethylbenzylamine (NMBzA), a potent increased incidence of oesophageal carcinoma in oesophageal carcinogen (Druckrey, 1972) , is different parts of the world and 75% of oesopha-ideally suited to determine the relative contribugeal cancers in the USA are attributed to alcohol tion of ethanol to oesophageal tumorigenesis. consumption (Rothman el al., 1980) . There are NMBzA occurs as a contaminant in areas of multiple mechanisms involved in cancer risk high incidence for oesophageal cancer in China associated with alcohol consumption (Garro and (Yang, 1980) , and microsomes that are prepared Lieber, 1990) . Since ethanol per se is not from the rat oesophageal mucosa metabolize carcinogenic, for studies of ethanol effects, NMBzA preferentially in comparison with the microsomes from the liver (Labuc and Archer, 1982) . Our recent studies have shown that ethanol, •Author to whom correspondence should be addressed. administered after tumour induction by NMBzA, caused a significant increase of oesophageal tumours in rats (Mufti et al., 1989) and mice (Odeleye et al., 1992) . Our other studies have shown that ethanol metabolism stimulated tumorigenesis that was induced by 7,12-dimethylbenz-(a)anthracene in the buccal mucosa of hamsters , and by W-nitrosonornicotine (NNN) and Af-nitrosaminomethylpyridylbutanone (NNK), the tobacco-specific carcinogens in the rat oesophagus, lung and liver (Nachiappan et al., 1994) , thus confirming that ethanol acts as a tumour promoter. In the above and other studies (Mufti, 1991 (Mufti, ,1993 Eskelson et al., 1993) , we also found that the tumour-promoting action of ethanol was associated with its ability to generate free radicals, as indicated by increased indices of lipid peroxidation. This report presents data indicating that the increased free radicals or lipid peroxidation products generated during ethanol metabolism in the oesophagus of NMBzA-treated rats are tumour promoters ascribed to ethanol. To further support the association of lipid peroxidation and/ or free radicals with rumour promotion by ethanol, data from these studies indicate significant changes in the fatty acid profile of phospholipids in the rat oesophagus compared to the liver.
MATERIALS AND METHODS

Animals and their diet
Six-week-old weanling male Sprague-Dawley rats (weight 100-120 g) were purchased from Taconic Inc., Germantown, NY, USA. The animals were quarantined for a week after arrival to ensure that they were free of any infections and then housed in suspended cages at the University Animal Care facility. This room has a regulated temperature of 23°C, humidity of 30-40%, and day and night cycles of 16 h and 8 h respectively.
Six rats were assigned to each treatment group. The rats were fed regular Purina rat chow before and during treatments with the carcinogen. A week after carcinogen treatment, the animals were fed an isocaloric liquid diet purchased from Dyets Inc. (Bethlehem, PA, USA) that is formulated according to the recommendations of Lieber and DeCarli (1982) and includes minerals and vitamins for rats as described by the American Institute of Nutrition (Bieri et al., 1977) . Ethanol constituted 7% of the diet in gram weight or 36% of total caloric intake. Dextrin-maltose substituted for ethanol calories in the control diet. Corn, olive and safflower oils constituted the source of lipids in both diets, contributing 35% of the caloric intake (Lieber and DeCarli, 1982) and consisted of 13.2% C16, 0.8% C16:l, 3.4% C18, 50.8% C18:l, 30.7% C18:2 and 1.1% C18:3 . Animals were pair fed to the ethanolconsuming counterparts and continued receiving this diet until they were killed at 10 months. The blood ethanol concentration was checked by gas chromatographic analysis (Taylor et al., 1984) . The range of variation in blood alcohol concentrations observed was between 0.08 and 0.12 mg/dl with a mean of 0.10 mg/dl and showed no significant variation during the course of study.
Treatment of animals
NMBzA (purchased from Ash Stevens, Chicago, IL, USA) was verified as 99% pure by Dr Karl Schram of our clinical chemistry department through mass spectrometric-gas chromatographic analysis. The carcinogen was kept at 4°C. Two groups of animals were treated with NMBzA at a dose of 2.5 mg/kg body weight, intraperitoneally, three times a week for 3 weeks as previously reported (Mufti et al., 1989) . Corn oil was used as the vehicle for NMBzA treatment.
Measurement of ethane exhaled
Ethane exhaled by rats was measured a week before their death by a non-invasive procedure described by us previously (Szebeni et al., 1986) . Briefly, rats were placed in airtight metabolic chambers and ethane in the exhaled air was trapped on coconut charcoal that was cooled to dry ice temperature to adsorb ethane. Exhaled ethane was collected over 30-min cycles using fresh coconut charcoal (AUtech Assoc., Inc., Deerfield, IL, USA). The charcoal was then placed in a screw-cap test tube which was tightly sealed and its contents heated to 240°C to desorb the ethane. Ethane was determined by a HewlettPackard gas chromatograph equipped with a flame ionization detector and a carbosphere column (Supelco, Bellefonte, PA, USA). The percentage recovery of ethane exhaled was 95 ± 10% using pure ethane as standard.
Lipid extraction of samples
Oesophageal mucosal tissue was initially ground in liquid nitrogen. The amounts of oesophageal tissue used varied from 100 to 190 mg. Lipid extraction was carried out on an aliquot of the extract from each individual oesophagus. The oesophageal extract and 500 mg of the liver were homogenized in 10 ml of a 2:1 (v/v) chloroform-methanol solution (Folch reagent) . Following mixing they were allowed to stand at 4°C for 16-18 h (Folch et al, 1957) . The homogenate was then centrifuged and the supernatant was used for the following determinations.
Cholesterol measurement
Cholesterol in the lipid extract was measured as described by Zak (1957) . Aliquots of the standard cholesterol and Folch extract of test samples were dried in a water bath at 70 c C and then 3 ml of Zak's solution were added and mixed. Sulphuric acid (2 ml) was added to each tube, then Immediately vortexed. The cholesterol colour was measured at 560 run in a Beckman DU-7 spectrophotometer.
Phospholipid (PL) determination
Phospholipid contents of the tissues were determined according to the method of Raheja et al. (1973) . Aliquots of the lipid extract were dried in a water bath at 70 c C, then 0.4 ml of chloroform and 0.2 ml of a chromogenic solution were mixed with the dried extract and placed in a boiling water bath for 1-1.5 min. The tubes were cooled to room temperature, 4 ml of chloroform were then added, mixed and centrifuged. The lower blue organic phase was carefully removed using Pasteur pipettes and the absorbance of phospholipids was measured at 710 nm.
Determination of conjugated-dienes, conjugatedtrienes and lipid fluorescence
Conjugated dienes and trienes were determined in 0.1 ml samples of the lipid extract. Folch reagent (1 ml) was added to the lipid extract and the solution washed twice with water. Then 1 ml of ethanol was added to remove water as an azeotrope. The mixture was dried in a nitrogen current at 55°C and the residue was redissolved in hexane. Diene-and triene-conjugates were measured at 232 and 268 nm, respectively. The hexane phase was also used to measure lipid fluorescence by excitation at 395 nm and an emission wavelength of 470 nm in a Hitachi F-2000 fluorescence spectrophotometer.
Malondialdehyde (MDA) determination
MDA, a decomposition product of lipid peroxidation, was determined by measuring the thiobarbituric acid (TBA) reactive products, since >80% of TBA-reactive products are MDA. MDA was measured by a modified procedure described by Ernster and Nordenbrand (1973) . The coloured MDA product was extracted in 3 ml of isobutanol and measured at 532 nm. A calibration curve was calculated by using MDA-bis-dimethyl acetal (Aldrich, Milwaukee, WI, USA) as a standard. The tissue TBA-reactive products were expressed as nmoles of MDA/g wet wt.
Protein estimation
Protein was estimated by the bicinchoninic acid protein assay reagent purchased from Pierce Company (Rockford, IL) using bovine serum albumin as standard as described by Smith et al. (1985) .
Tissue glutathione determination
Tissue glutathione was determined according to the method of Sedlak and Lindsay (1973) . Tissue (50 mg) was homogenized in 1 ml of medium containing 0.2 M Tris-HCl, pH8.9 and 10 mM EDTA and the homogenate was microfuged for 30 s to remove the cell debris. To 0.45 ml of the supernatant 0.05 ml of 50% TCA was added, cooled on ice for 10 min and microfuged at full speed for 10 min to remove the precipitate. A 0.4 ml sample of the supernatant was adjusted to pH 8.0 with Tris-base and then 0.1ml of freshly prepared 0.1 mM 5,5'-dithiobis(2-nitrobenzoic acid) was added and the absorbance measured at 412 nm. A standard curve was run in a similar manner to obtain the levels of glutathione in the tissue.
Tissue vitamin E determination
The total vitamin E was determined fluorimetrically as described by Palan et al. (1973) . The lipid extracts were dried under nitrogen and the residues were suspended in 1 ml of ethanol followed by the addition of 4 ml of hexane and 0.6 ml of 60% sulphuric acid. The tubes were then vortexed and centrifuged. The upper hexane phase was removed and its fluorescence intensity was measured at an emission wavelength of 340 nm and excitation at 295 nm using a a-tocopherol to establish a standard curve.
Phospholipid fatty acid analysis
Phospholipid fatty acid analysis of oesophageal mucosal tissue was determined by a modification of a previously published method . Briefly, according to this method, to 1 ml of the Folch extract 200 ug of diheptadecanoyl phosphatidyl choline were added as an internal standard and the solution treated as in the above reference.
Peroxidation index
The peroxidation index (Witting and Horwitt, 1964) was calculated as an index of the amount of substrate for lipid peroxidation based on the contribution of fatty acids according to their degree of unsaturation. Thus, the oxidative deterioration of fatty acids increases as the number of double bonds increases. Peroxidation index (PI) was determined from the percentages of monoenoic, dienoic, trienoic, tetraenoic, pentaenoic and hexaenoic fatty acids according to the following formula: PI = (Monoenoic % x 0.025) + (Dienoic % x 1) + (Trienoic % x 2) + (Tetraenoic % x 4) + (Pentaenoic % x 6) + (Hexaenoic % x 8)
Statistical analysis
The fatty acid data are expressed as the average percentage of the fatty acids in the profile, with the standard deviation (SD) of the six rats in the group. Cholesterol and phospholipid are expressed as mg/g of wet tissue and lipid fluorescence and diene and triene conjugates absorption or fluorescence as units/g wet tissue. MDA and glutathione are expressed respectively as pmoles or nmoles/ mg of protein. Vitamin E is expressed as (j.g/g of wet tissue.
Data were analysed using Duncan's multiple range test (Duncan, 1955) with P < 0.05 values considered as statistically significant. The Duncan analysis was used to compare all means in the groups; the analysis was performed using a computer.
RESULTS
Effect of ethanol consumption for 10 months on cumulative ethane exhaled by Sprague-Dawley rats treated with NMBzA
Cumulative ethane, nmol/kg body weight, exhaled by rats over a period of 150 min is shown in Fig. 1 . NMBzA treatment of rats fed control diets significantly increased (P < 0.05) the cumulation of ethane. Ethanol-fed rats treated with NMBzA and rats fed ethanol alone even caused a further increase (P < 0.001) in ethane excretion. This increase appeared synergistic rather than additive. The largest increases of ethane excretion were exhibited by rats that were treated with NMBzA and consumed an ethanol diet.
Effect of ethanol consumption for 10 months on hepatic cholesterol, phospholipids, indices of lipid peroxidation, and the antioxidants glutathione and vitamin E in NMBzA-treated Sprague-Dawley rats
The levels of cholesterol, mg/g hepatic tissue, did not change with NMBzA treatment in rats fed the control liquid diet; however, ethanol consumption by both the NMBzA-untreated and NMBzAtreated rats caused a significant increase (P < 0.01-0.05) in cholesterol levels (Table 1) . Similarly, hepatic phospholipid levels (mg/g liver) were not affected by NMBzA alone, but were increased significantly during ethanol consumption in both the NMBzA-untreated and NMBzAtreated rats (P < 0.001).
Measurements of indices of hepatic lipid peroxidation (MDA, diene-and triene-conjugates and lipid fluorescence) showed that, except for diene-conjugates which exhibited a significant increase (P < 0.05), all other indices did not change significantly with NMBzA treatment in the control-fed rats. However, ethanol consumption caused a significant increase (P < 0.001-0.05) in all these indices (Table 1) , which was more pronounced when the rats were also treated with NMBzA.
Measurements of hepatic glutathione (nmol/mg of protein) and vitamin E (g/mg phospholipid) showed that ethanol consumption caused a significant decrease in both parameters (P < 0.001-0.01). NMBzA treatment did not potentiate the ethanol effect nor exert any effects in rats as regards vitamin E and glutathione levels (Table 1) . 
Effect of ethanol consumption for 10 months on oesophageal cholesterol, phospholipids, indices of lipid peroxidation, and the antioxidants glutathione and vitamin E in NMBzA-treated Sprague-Dawley rats
The levels of cholesterol and the phospholipids (in mg/g of oesophageal tissue) were not affected with NMBzA treatment in the control-fed rats, but ethanol consumption by either the untreated or NMBzA-treated rats caused a significant increase (P < 0.001) ( Table 2) .
No significant alteration in any of the indices of lipid peroxidation in the oseophagus was apparent with NMBzA treatment in the control-fed rats (apart from a small increase in trienes), however, lipid peroxidation increased in all ethanol-fed rats. The largest increases were observed in rats that were treated with both NMBzA and ethanol (P < 0.001-0.01); the extent of increase over NMBzA-treated control-fed rats ranged from 29% for triene-conjugates to 77% for MDA.
NMBzA treatment of the control-fed rats caused a significant decrease (P < 0.05) in oesophageal glutathione (nmol/mg of protein). Ethanol consumption caused a larger decrease (P < 0.001) in glutathione but there was no difference whether the ethanol-fed rats were untreated or NMBzA-treated. Vitamin E (expressed per g tissue) showed no change with the NMBzA treatment, but expressed per phospholipid weight showed an increase with NMBzA treatment of the control-fed rats. However, while vitamin E per g tissue or phospholipids decreased significantly (P < 0.001-0.01) with ethanol consumption by the untreated rats; ethanol in combination with NMBzA caused a reversal of the observed decrease.
Effect of ethanol consumption for 10 months on percentage composition of hepatic phospholipid fatty acids from NMBzA-treated Sprague-Dawley rats
A comparison of the hepatic phospholipid fatty acid profile between rats fed ethanolic diets and rats fed alcohol-free diets for 10 months indicated significant alterations. However, the differences were significant in those fatty acids in the profile that were at low percentage, i.e. <3.7% (Table 3) ; for example, C20 of the profile increased from 0.09 to 0.13%, which is a significant 44% increase of that fatty acid. Also, the hepatic phospholipid fatty acid profile of rats treated with NMBzA compared with the untreated control-fed rats showed increases in the percentages of C14, C18:l, C18:2, C20, C20:l, C20:2, C20:3, C20:3' (homogamma linolenate) and C22:6. The percentages of C18, C18:2, C20:4 and C22 remained unchanged, whereas the percentages of palmitoleate (C16:l) and C22:l were decreased. Rats treated with NMBzA with or without ethanol feeding showed increased percentages of C14, C16:l, C18:3, C20; C20:l, C20:2, C20:3 and C22:l (most are unsaturated fatty acids), compared to the hepatic phospholipid fatty acid profile from rats treated with NMBzA but fed nonalcoholic diet. Ethanol-fed rats that were treated with NMBzA, when compared with the untreated ethanol-fed rats, showed increased percentages in C14, C14:l, C18:l, C18:3, C20, C20:l, C20:2, C20:3', C22, C22:l and C22:6, but C16, C16:l, C20:3 and C20:4 decreased and C18, C18:2, C20:3 and C20:4 remained unchanged. 36.27 ± 3.37"'* 25.41 ± 2.66"* 1.00 ± 0.14"**
Values are means ± SD for six rats. "Control (-NMBzA) compared with alcohol (-NMBzA) and control ( +NMBzA) compared with alcohol ( +NMBzA). b Control (-NMBzA) compared with control (+NMBzA) and alcohol (-NMBzA) compared with alcohol ( + NMBzA). Statistically significant alterations: *P < 0.05; **P < 0.01; *"P < 0.001.
Effect of ethanol consumption for 10 months on percentage composition of oesophageal phospholipid fatty acids from Sprague-Dawley rats treated with NMBzA
Oesophageal phospholipid fatty acid profile from alcohol-fed rats compared with non-alcohol-fed rats (both not treated with NMBzA) indicated significantly decreased percentages of C14, C14:l, C16, C16:l, C18, C20, C20:l and C22, but increased C18:l, C18:2, C20:3, C22:l and C22:6 (Table 4) . A comparison of the profile of NMBzA-treated, with the untreated, rats that were fed the control diet showed significant increases in C14, C20, C20:l, C20:2, C20:3, C22, C22:l and C22:6, whereas C16:l, C18:2 and C20:4 were decreased and C14:l, C16. C18 and C18:l showed little or no change. When oesophageal phospholipid fatty acid profiles from ethanolfed NMBzA-treated rats were compared with Values are means ± SD for six rats. 'Control (-NMBzA) compared with alcohol (-NMBzA) and control ( +NMBzA) compared with alcohol ( +NMBzA). b Control (-NMBzA) compared with control ( + NMBzA) and alcohol (-NMBzA) compared with alcohol (+NMBzA). Statistically significant alterations: *P < 0.05; **P < 0.01; ***P < 0.001. 12.72 ± 1.39"* 0.38 ± 0.03*"*-b *" 22.80 ± 2.57 10.19 ± 1.14 b " 10.68 ± 1.14 2.38 ± 0.32 1 *"-"'" ND 1.77 ± 0.24*"*' "•" 1.16 ± 0.12 b *" 0.69 ± 0.07**"' b "' 1.16 ±0.14 25.66 ± 2.49
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Values are means ± SD for six rats. "Control (-NMBzA) compared with alcohol (-NMBzA) and control (+NMBzA) compared with alcohol (+NMBzA). ""Control (-NMBzA) compared with control (+NMBzA) and alcohol (-NMBzA) compared with alcohol ( + NMBzA). Statistically significant alterations: *P < 0.05; **P < 0.01; *"P < 0.001. PI = peroxidation index; ND = not detected.
control-fed NMBzA-treated rats, there were increased percentages of C14, C16:l, C18:3, C20, C20:l, C20:2, C20:3', C20:4, C22 and C22:6, whereas the percentages of C14:l, C16 and C22:l were decreased and those of C18:l, C18:2 and C20:3 showed little or no change. Also, ethanol feeding of NMBzA-treated, compared with untreated, rats showed substantial increases in percentages of C14, C16:l, C20, C20:l, C20:2, C20:3, C20:3', C22, C22:l and C22:6, but percentage decreases were observed in C14:l, C16, C18, C18:l and C18:2. The peroxidation index (PI) for oesophageal phospholipid fatty acid profile was significantly increased (P < 0.01-0.05) with ethanol consumption, regardless of NMBzA treatment, which caused some increase (Table 4) . However, the PI for hepatic phospholipids was not significantly altered during ethanol metabolism or with NMBzA treatment (Table 3 ). The change of the phospholipid PI with alcohol metabolism was associated with a decrease in the percentage of saturated fatty acids in contrast with an increase in the percentage of the larger (C20-C22) polyunsaturated fatty acids.
DISCUSSION
A variety of structurally unrelated xenobiotics that cause lipid peroxidation (i.e. generate free radicals) have been shown to cause rumour promotion (Copeland, 1983; Cerutti, 1985; Witz, 1991) . Ethanol metabolism generates free radicals when it and/or its metabolites are oxidatively metabolized by the micTosomal ethanol-oxidizing system (MEOS) (for a recent review, see Mufti et ai, 1993) . The MEOS is derived from the endoplasmic reticulum (ER) containing an ethanol-inducible form of cytochrome P-450 called P450 2E1 or CYP2E1 (Koop and Coon, 1985) , which plays an important role in generating reactive oxygen species (Ingelman-Sundberg and Johansson, 1981; Gorsky et ai, 1984) . In recent studies, we observed that ethanol administered ± 0.01"" ± 0.03"** ± 1.59*" ±0.06 ± 1.65" ± 1.81" ± 2.02"* ND ND ± 0.05" *• ± 0.03" ± 0.05" ± 0.14"** ±2.09 ND ±0.11"" ± 0.08"" ND ± 0.31"" ± 0.13*"*' b *" ± 0.03"" ± I AT** ± 0.31"* after treatment with NMBzA caused an increased incidence of oesophageal tumours both in rats (Mufti et al., 1989) and mice (Odeleye et al., 1992) and the ethanol-related promotion of NMBzA-induced carcinogenesis was associated with an increase in ethane exhalation as well as other hepatic lipid peroxidation products (Mufti, 1991 (Mufti, , 1993 Odeleye et al., 1992; Eskelson et al., 1993) . Furthermore, an increase in lipid peroxidation products was directly associated with increased tumour incidence . However, in the previous studies, only hepatic lipid peroxidation products were determined, whereas the oesophageal free radical activity was not measured. ' The results reported here indicate that all indices of lipid peroxidation registered a significant increase in the liver which is the major site for ethanol and NMBzA metabolism (Labuc and Archer, 1982) . The oseophagus, where the rumours are induced by NMBzA, also contains MEOS (Farinati et al., 1985) . The results reported here thus indicate that increased lipid peroxidation occurs in this NMBzA target tissue with ethanolinduced tumour promotion. The results are consistent with other findings from this laboratory. For example, ethanol promotion of hamster buccal carcinogenesis induced by 7,12-dimethylbenz-(a)anthracene is accompanied by increased lipid peroxidation in the buccal mucosa . Similarly, both lipid peroxidation and tumours are increased in the rat oesophagus, lungs and liver with ethanol promotion following tumour induction by the tobacco carcinogens, NNN and NNK (Nachiappan et al., 1994) . Acute ethanol administration lowers the levels of the antioxidant glutathione (for example, see Speisky et al., 1985) , but the effects of chronic ethanol consumption are varied. In this study the levels of glutathione decreased significantly with ethanol metabolism, both in the liver and oesophagus of the NMBzA-treated or untreated rats. However, whereas vitamin E levels decreased with ethanol consumption in both the liver and oesophagus of rats not treated with the carcinogen, its levels increased in the oesophagus when ethanol use was combined with the NMBzA treatment. Increases in vitamin E levels are associated with decreased membrane fluidity (Patel and Edwards, 1988) , and therefore, may present an adaptive response to oxidative stress with induction of the oesophageal tumours and the increased fluidity caused by ethanol. A similar argument for increases in vitamin E was advanced by Dianzanni (1989) for rumours induced in the liver.
Subcellular organelles such as the ER are composed of large amounts of phospholipids. Thus, fatty acid composition of the phospholipids of the liver and oesophagus was particularly interesting to study, also because of the presence in the ER of MEOS, which metabolizes ethanolreleasing free radicals. The results indicate that both ethanol and/or the induction of cancer changes the profile of the phospholipid fatty acids as well as changing lipid peroxidability. The overall profile of the hepatic phospholipid saturated vs unsaturated fatty acids with regard to their peroxidability was not substantially altered where tumours were not developing. However, it was significantly altered in the oesophageal phospholipids with ethanol metabolism, with an increase in polyunsaturated fatty acids (PUFA). Free radicals readily react with PUFA in membranes producing conjugated dienes and trienes, and cleaving PUFA-hydrocarbon chains to produce aldehydes (nonal, nonenal, malondialdehyde, etc.) . Because increased free-radical production is associated with ethanol metabolism, decreased amounts of PUFA may be expected in tissues undergoing ethanol metabolism. However, this was not observed in this study and may be caused by increased tumour development due to hyperregeneration occurring with chronic ethanol consumption (Mak et al., 1987) , or clonal expansion of the NMBzA-induced oesphageal lesions. We also wonder why the developing tumours seem to target the larger amount of the higher molecular weight PUFA. Increases in oesphageal phospholipid PUFA imply that free radicals generated during ethanol metabolism were at low activity, perhaps due to increased vitamin E, or it may be due to increased oesophageal uptake of phospholipid PUFA in plasma lipoproteins to meet oesophageal tumorigenic requirements. Based on our observations that an increased uptake of lung lipids was coordinated by increased lipogenesis and release by the liver (Eskelson et al., 1988) , we suggest that lipids from the large pool in the blood are utilized for tumour growth.
Since tumour promotion by ethanol metabolism occurred only with prior treatment of NMBzA (Mufti, et al., 1989) , the alterations that take place when ethanol use is combined with NMBzA are of interest. The increased PUFA level in oesophageal phospholipids under these conditions suggests that tumour cell membranes are more fluid than normal oesophageal cells. Furthermore, when ethanol use was combined with the NMBzA treatment, the hepatic phospholipids showed a substantial increase only in C18:3 (linolenic acid), with no increase in arachidonate (C20:4), but the oesophageal phospholipids showed a pronounced increase in the levels of C18:3, C20:2, C20:3, C20:3' and C22:6 and also a significant increase in arachidonate. Fatty acids with three or more double bonds are the most peroxidable (Dillard and Tappel, 1989) . Docosahexenoic acid (C22:6) is derived from linolenic acid (an co3 PUFA), whereas C20:3 is derived from linoleic acid (C18:2, an w6 PUFA), the two classes of PUFA which are essentially fatty acids, and since none of the above derivatives was supplied in the diet, they must have been synthesized in vivo by the rat tissues. The conversion of linoleate to arachidonate is a necessary step in lipid metabolism involved in a variety of physiological processes, which enables the synthesis of eicosanoids that are required for cell proliferation. This process of eicosanoid production is well regulated in normal tissues, but seems to be exaggerated in neoplasia (Karmali, 1987) , and an eicosanoid metabolic disorder has been reported in several malignancies (Karmali, 1987; Fischer et al., 1992) , as well as in alcoholic liver disease (French, 1993) . We propose that ethanol metabolism through excessive cell proliferation caused by a disorder in eicosanoid metabolism could induce selective outgrowth of the initiated cells leading to alcohol-related promotion. Chronic ethanol consumption has been shown to lead to hyper-regeneration in the rat oesophagus (Mak et al., 1987) and excessive cell proliferation is conducive to genetic errors in carcinogenesis (Cohen and Ellwein, 1991) . Ethanol-related promotion of NMBzA-induced oesophageal carcinogenesis discussed here fits this model of tumour promotion.
